Pharmaceutical - Mergers & Acquisitions, Boehringer Ingelheim


Popular Filters

Boehringer Ingelheim Venture Fund invests in Eyevensys


Paris, France-based Eyevensys, a developer of a new process for non-viral gene therapy using electrotransfer…

Boehringer IngelheimEyevensysFinancialMergers & AcquisitionsOphthalmicsPharmaceutical

In India, Lilly and Boehringer link for diabetes drug marketing; GSK eyeing acquisitions


The Indian subsidiaries of US drug major Eli Lilly (NYSE: LLY) and independent German pharma company…

Asia-PacificBoehringer IngelheimDiabetesEli LillyGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceutical

Back to top